Cardiogen
Also known as: Heart Peptide Bioregulator, Cardiac Bioregulator
A bioregulator peptide for cardiovascular health and cardiac tissue support.
Overview
Cardiogen is a synthetic tetrapeptide from the Khavinson bioregulator family designed to support heart function. It has been studied in Russia for various cardiovascular conditions and shows promise for cardiac aging and rehabilitation.
Mechanism of Action
Gene regulatory effects on cardiomyocytes. Proposed to normalize protein synthesis in cardiac tissue. May support mitochondrial function and reduce oxidative stress in heart cells.
Pharmacokinetics
Small peptide allows oral/sublingual administration. Tissue-specific effects on cardiac tissue.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Maintenance
10-20 mg
1-2x daily
10-30 days
2-3 courses per year
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Improved cardiac function markers in elderly patients
- 2Gene expression modulation in cardiac tissue
- 3Potential cardioprotective effects
- 4Part of geroprotective protocols in Russia
Side Effects & Contraindications
Reported Side Effects
- Generally well-tolerated
Contraindications
- Acute MI (seek emergency care)
Safety Considerations
Generally well-tolerated. Should complement, not replace, standard cardiac care.
Storage Requirements
Store at room temperature
Scientific References
- 1